AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Alsita M IR 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Alsita M IR 50mg/500mg Tablet

Diabetic patients with type 2 mellitus may benefit from the dual-action formula in MetDuo 50mg/500mg tablets, which effectively manages elevated blood glucose. This helps mitigate severe diabetic complications like vision impairment and renal dysfunction, potentially lessening the risk of cardiovascular events. MetDuo 50mg/500mg may be used independently or in conjunction with other anti-diabetic therapies, optimizing efficacy when paired with a balanced diet and regular physical activity. Dosage is individualized, considering factors such as overall health, blood glucose readings, and concurrent medications. Consuming the tablets with meals minimizes gastrointestinal discomfort. Consistent daily administration at the same time ensures optimal therapeutic impact; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regimen is vital for effective diabetes management, as lifestyle choices significantly influence blood sugar control. Commonly reported side effects include nausea, diarrhea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia, a potential side effect, particularly when used alongside insulin or sulfonylureas, necessitates familiarity with its symptoms and management. This medication isn't universally suitable. Prior to commencing treatment, individuals with pre-existing hepatic, renal, or cardiac conditions, pancreatic issues, or significant alcohol consumption should inform their doctor. Pregnant or lactating individuals also require medical consultation before use. Potential drug interactions necessitate comprehensive disclosure of all medications to the prescribing physician. Alcohol should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout the treatment period.

Primary Ingredients of Alsita M IR 50mg/500mg Tablet

There is no text provided to rephrase. Please provide the text you wish to be rewritten.

Uses of Alsita M IR 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Alsita M IR 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Alsita M IR 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Alsita M IR 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Alsita M IR 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Alsita M IR 50mg/500mg Tablet should be administered with a meal.

How Alsita M IR 50mg/500mg Tablet works:

Alsita M IR 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Alsita M IR 50mg/500mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Alsita M IR 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Alsita M IR 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Alsita M IR 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Alsita M IR 50mg/500mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Alsita M IR 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Alsita M IR 50mg/500mg Tablet :

Should you forget to take your Alsita M IR 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alsita M IR 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Alsita M IR 50mg/500mg Tablet

Alsita M IR 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not for use in patients under 18.
Prolonged use of Alsita M IR 50mg/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia and neurological issues, including numbness, tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Alsita M IR 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Alsita M IR 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Alsita M IR 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Alsita M IR 50mg/500mg Tablets. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Alsita M IR 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Alsita M IR 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Alsita M IR 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Alsita M IR 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Yes, Alsita M IR 50mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is why the medication is avoided in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Alsita M IR 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Alsita M IR 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Alsita M IR 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Alsita M IR 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Alsita M IR 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency caused by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Alsita M IR 50mg/500mg Tablet. This rare complication is avoided in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Alsita M IR 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Alsita M IR 50mg/500mg Ta...
96